These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30958365)

  • 1. A 2.5-Year Longitudinal Assessment of Naturalistic Driving in Preclinical Alzheimer's Disease.
    Roe CM; Stout SH; Rajasekar G; Ances BM; Jones JM; Head D; Benzinger TLS; Williams MM; Davis JD; Ott BR; Warren DK; Babulal GM
    J Alzheimers Dis; 2019; 68(4):1625-1633. PubMed ID: 30958365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Naturalistic Study of Driving Behavior in Older Adults and Preclinical Alzheimer Disease: A Pilot Study.
    Babulal GM; Stout SH; Benzinger TLS; Ott BR; Carr DB; Webb M; Traub CM; Addison A; Morris JC; Warren DK; Roe CM
    J Appl Gerontol; 2019 Feb; 38(2):277-289. PubMed ID: 28380718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Naturalistic Driving Behavior Using In-Vehicle Monitoring Technology in Preclinical and Early Alzheimer's Disease.
    Davis JD; Babulal GM; Papandonatos GD; Burke EM; Rosnick CB; Ott BR; Roe CM
    Front Psychol; 2020; 11():596257. PubMed ID: 33192943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression and Alzheimer's Disease Biomarkers Predict Driving Decline.
    Babulal GM; Chen S; Williams MM; Trani JF; Bakhshi P; Chao GL; Stout SH; Fagan AM; Benzinger TLS; Holtzman DM; Morris JC; Roe CM
    J Alzheimers Dis; 2018; 66(3):1213-1221. PubMed ID: 30400098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.
    Roe CM; Babulal GM; Mishra S; Gordon BA; Stout SH; Ott BR; Carr DB; Ances BM; Morris JC; Benzinger TLS
    J Alzheimers Dis; 2018; 61(2):509-513. PubMed ID: 29171997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Preclinical Alzheimer's Disease Using Everyday Driving Behavior: Proof of Concept.
    Babulal GM; Johnson A; Fagan AM; Morris JC; Roe CM
    J Alzheimers Dis; 2021; 79(3):1009-1014. PubMed ID: 33361605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Driving Outcomes Among Cognitively Normal African American and Caucasian Older Adults.
    Babulal GM; Stout SH; Williams MM; Rajasekar G; Harmon A; Vivoda J; Zuelsdorff M; Benzinger TLS; Morris JC; Ances B; Roe CM
    J Racial Ethn Health Disparities; 2020 Apr; 7(2):269-280. PubMed ID: 31686371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse driving behaviors are associated with sleep apnea severity and age in cognitively normal older adults at risk for Alzheimer's disease.
    Doherty JM; Roe CM; Murphy SA; Johnson AM; Fleischer E; Toedebusch CD; Redrick T; Freund D; Morris JC; Schindler SE; Fagan AM; Holtzman DM; Lucey BP; Babulal GM
    Sleep; 2022 Jun; 45(6):. PubMed ID: 35303111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturalistic Driving Study Investigating Self-Regulation Behavior in Early Alzheimer's Disease: A Pilot Study.
    Paire-Ficout L; Lafont S; Conte F; Coquillat A; Fabrigoule C; Ankri J; Blanc F; Gabel C; Novella JL; Morrone I; Mahmoudi R
    J Alzheimers Dis; 2018; 63(4):1499-1508. PubMed ID: 29782312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creating a driving profile for older adults using GPS devices and naturalistic driving methodology.
    Babulal GM; Traub CM; Webb M; Stout SH; Addison A; Carr DB; Ott BR; Morris JC; Roe CM
    F1000Res; 2016; 5():2376. PubMed ID: 27990264
    [No Abstract]   [Full Text] [Related]  

  • 11. Driving assessment in preclinical Alzheimer's disease: progress to date and the path forward.
    Bayat S; Roe CM
    Alzheimers Res Ther; 2022 Nov; 14(1):168. PubMed ID: 36348410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driving Difficulties Among Patients with Alzheimer's Disease and Other Neurodegenerative Disorders.
    Fuermaier ABM; Piersma D; de Waard D; Davidse RJ; de Groot J; Doumen MJA; Bredewoud RA; Claesen R; Lemstra AW; Scheltens P; Vermeeren A; Ponds R; Verhey F; De Deyn PP; Brouwer WH; Tucha O
    J Alzheimers Dis; 2019; 69(4):1019-1030. PubMed ID: 31045516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.
    Baker JE; Lim YY; Jaeger J; Ames D; Lautenschlager NT; Robertson J; Pietrzak RH; Snyder PJ; Villemagne VL; Rowe CC; Masters CL; Maruff P
    J Alzheimers Dis; 2018; 65(3):977-988. PubMed ID: 30103330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Driving Cessation Among Cognitively Normal Older Drivers: The Role of Alzheimer Disease Biomarkers and Clinical Assessments.
    Babulal GM; Chen L; Murphy SA; Carr DB; Morris JC
    Neurology; 2024 Jun; 102(12):e209426. PubMed ID: 38776513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPS driving: a digital biomarker for preclinical Alzheimer disease.
    Bayat S; Babulal GM; Schindler SE; Fagan AM; Morris JC; Mihailidis A; Roe CM
    Alzheimers Res Ther; 2021 Jun; 13(1):115. PubMed ID: 34127064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology.
    Gordon BA; Blazey T; Su Y; Fagan AM; Holtzman DM; Morris JC; Benzinger TL
    JAMA Neurol; 2016 Oct; 73(10):1192-1200. PubMed ID: 27548756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Brief Version of the LASSI-L Detects Prodromal Alzheimer's Disease States.
    Crocco E; Curiel-Cid RE; Kitaigorodsky M; González-Jiménez CJ; Zheng D; Duara R; Loewenstein DA
    J Alzheimers Dis; 2020; 78(2):789-799. PubMed ID: 33074233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the global positioning system on the driving performance of people with mild Alzheimer's disease.
    Yi J; Lee HC; Parsons R; Falkmer T
    Gerontology; 2015; 61(1):79-88. PubMed ID: 25342271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
    Bransby L; Lim YY; Ames D; Fowler C; Roberston J; Harrington K; Snyder PJ; Villemagne VL; Salvado O; Masters CL; Maruff P
    J Clin Exp Neuropsychol; 2019 Aug; 41(6):591-600. PubMed ID: 30924399
    [No Abstract]   [Full Text] [Related]  

  • 20. Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.
    Edmonds EC; Bangen KJ; Delano-Wood L; Nation DA; Furst AJ; Salmon DP; Bondi MW;
    J Int Neuropsychol Soc; 2016 Nov; 22(10):978-990. PubMed ID: 27903335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.